Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: results of a multicenter 6-week dose-response trial.
about
Interventions for basal cell carcinoma of the skinInterventions for basal cell carcinoma of the skinAdvances in the use of topical imiquimod to treat dermatologic disordersBasal cell carcinomaSuccessful treatment of extramammary Paget's disease of the scrotum with imiquimod 5% cream.Treatment of large facial Bowen's disease: case report.Imiquimod: an immune response modifier in the treatment of precancerous skin lesions and skin cancer.Pharmacologic therapy for periocular infantile hemangiomas: a review of the literature.Depigmentation therapies for normal skin in vitiligo universalis.The SINS trial: a randomised controlled trial of excisional surgery versus imiquimod 5% cream for nodular and superficial basal cell carcinoma.Treatment of verrucous carcinoma of the lower lip with topical imiquimod (aldara®) and debulking therapy.Experience in treating molluscum contagiosum in children with imiquimod 5% cream.What is new in therapy?Imiquimod as a dermatological therapy.Imiquimod: a potential role in dermatology?Imiquimod; an international update on therapeutic uses in dermatology.Imiquimod and the imidazoquinolones: mechanism of action and therapeutic potential.The imidazoquinolines and their place in the therapy of cutaneous disease.Current treatment patterns in non-melanoma skin cancer across Europe.Summary of actinic keratosis studies with imiquimod 5% cream.The use of Toll-like receptor-7 agonist in the treatment of basal cell carcinoma: an overview.Combined imiquimod and acitretin for non-surgical treatment of basal cell carcinoma.Squamous cell carcinoma in situ of the skin: history, presentation, biology and treatment.Interventions for basal cell carcinoma of the skin: systematic review.Intratumoral immunotherapy: using the tumour against itself.Imiquimod attenuates the growth of UVB-induced SCC in mice through Th1/Th17 cells.Photodynamic therapy and imiquimod immunotherapy for basal cell carcinomas.Trial watch: FDA-approved Toll-like receptor agonists for cancer therapy.The small-molecule immune response modifier imiquimod--its mode of action and clinical use in the treatment of skin cancer.Immunoprevention of basal cell carcinomas with recombinant hedgehog-interacting protein.Current modalities and new advances in the treatment of basal cell carcinoma.Guidelines for the management of basal cell carcinoma.Treatment of cutaneous tumors with topical 5% imiquimod cream.Treating skin cancer with topical cream.Acute renal failure caused by imiquimod 5% cream in a renal transplant patient: review of the literature on side effects of imiquimod.Successful treatment and management of large superficial basal cell carcinomas with topical imiquimod 5% cream: a case series and review.Overall treatment success after treatment of primary superficial basal cell carcinoma: a systematic review and meta-analysis of randomized and nonrandomized trials.Topical treatment of basal cell carcinoma with the immune response modifier imiquimod.Imiquimod in dermatology: an overview.Clearance of folliculotropic and tumor mycosis fungoides with topical 5% imiquimod.
P2860
Q24246327-AAB733CD-16E5-42C6-83F1-9C49EC10E68FQ24248724-1661D4E4-AFC2-4A36-B6EE-F91BBAD1AFCEQ24647413-5FAC3372-5C15-484D-8AEA-115D7D4E3B6AQ24677030-CE1B8340-A236-484D-BB27-60B4FFFFBAB8Q31025216-A8CE9EB9-C9FA-43C1-990F-7BDF14187FC8Q33195011-24F94E96-9BE2-41CC-9DED-5549319E8C16Q33293591-CD1EACCA-C0B6-414E-9C55-AB98B2565B97Q33444923-95FD2494-BD00-4AB0-9C86-F7CA18040863Q33739817-1CF86E2C-C62E-4705-A9FA-C3D6866AE809Q33878766-F2AC16CA-819D-4E6B-B926-C15953EEDE69Q34057975-30CEF7CA-07E0-4A48-A195-25BD8C54483CQ34276705-AC303A2E-825C-4122-8758-18B8C0663E43Q34459067-10BFD2DC-027B-4693-A592-D75B7ADDB57BQ34546035-6C959A21-DB2B-44DB-BB45-F1DB6BACA175Q34722728-36ADE275-A6B1-49D1-95E9-C773F9912360Q35009563-625B7813-81D7-42A0-8881-1E3B919BD170Q35015851-4EDD583B-281F-4EEF-A6F0-D03300EB995DQ35164704-7DED9551-0A8C-4374-9DC2-265C9276BD20Q35548847-745A7C8C-1ABD-4DDC-9EFE-3D3BCFB5265AQ35583162-AE22E84F-1CD1-47BA-AD59-4FF2DEC325B0Q35583168-C97053AE-74FF-43F2-B1E7-72E394BABB9EQ35597888-4F1B8115-B439-497D-A719-FE90C0585145Q35666541-2D2C2564-3AD4-4AD7-861C-46D1CE1020DAQ35886161-A7B2DB9B-1338-42DB-99B7-690B57F3BA45Q35988030-DCE68442-B677-4F79-BB6A-1FA635B4CB3EQ36096165-8F3BEA0E-C54F-47C3-AD47-875EAEFBF352Q36362591-A284E129-E764-442F-B3AE-9861D7ADDB84Q36373370-7D5722B0-333B-4896-8A6A-AE7322F23DC3Q36379372-82C5D59A-6CB9-4191-812E-6312850B9B5AQ36402362-A1C9383C-28A5-4908-AEC0-83C5EF6B6BE9Q36478773-A62AAC2A-3972-4CDD-A051-767AD5A6DE0AQ37204336-26527569-F564-4600-8E91-94D505C55C40Q37389843-9578A772-CC89-4FCE-88A4-0FEFA2A9AFBDQ37735187-EFB4EE57-D440-44A0-B259-2AF61A94D2A3Q37838175-219CC714-467A-46B9-B3A6-C89212CF56B4Q37903872-F0FC6308-0B65-4297-9444-10192F4C96ACQ38011775-D191F2E9-25D8-44C1-87E3-9F57D8016755Q38602867-320F6101-0054-40BA-A5E5-7D2170827AA4Q38888889-500417A2-5B07-40F2-B918-E34AC487A10EQ39557726-63F37F12-CEFF-49F9-BC73-D49D60428C54
P2860
Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: results of a multicenter 6-week dose-response trial.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Imiquimod 5% cream in the trea ...... er 6-week dose-response trial.
@en
Imiquimod 5% cream in the trea ...... er 6-week dose-response trial.
@nl
type
label
Imiquimod 5% cream in the trea ...... er 6-week dose-response trial.
@en
Imiquimod 5% cream in the trea ...... er 6-week dose-response trial.
@nl
prefLabel
Imiquimod 5% cream in the trea ...... er 6-week dose-response trial.
@en
Imiquimod 5% cream in the trea ...... er 6-week dose-response trial.
@nl
P2093
P356
P1476
Imiquimod 5% cream in the trea ...... er 6-week dose-response trial.
@en
P2093
Australasian Multicentre Trial Group
P304
P356
10.1067/MJD.2001.113689
P407
P577
2001-05-01T00:00:00Z